製品番号: HY-146067

β-Nor-lapachone

β-Nor-lapachone is a Candida glabrata antibiofilm agent. β-Nor-lapachone can stimulate ROS production, inhibits efflux activity, adhesion, biofilm formation and the metabolism of mature biofilms of Candida glabrata. β-Nor-lapachone has antifungal activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 52436-88-1
分子式: C₁₄H₁₂O₃
分子量:228.24

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (284 KB)

β-Nor-lapachone 構造式

CAS 番号: 52436-88-1

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

Candida glabrata, ROS^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	10 μM Compound: 3	Cytotoxicity against human A549 cells after 72 hrs by MTT assay Cytotoxicity against human A549 cells after 72 hrs by MTT assay	[PMID: 25677663]
A549	IC₅₀	20 μM Compound: 3	Cytotoxicity against human A549 cells after 72 hrs by MTT assay in presence of NQO1 inhibitor dicoumarol Cytotoxicity against human A549 cells after 72 hrs by MTT assay in presence of NQO1 inhibitor dicoumarol	[PMID: 25677663]
CCRF-CEM	IC₅₀	15.2 μM Compound: 8	Cytotoxicity against human CCRF-CEM cells after 48 hrs by Alamar blue assay Cytotoxicity against human CCRF-CEM cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
DU-145	IC₅₀	1.386 μM Compound: Page 1994, R38C1	Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
DU-145	IC₅₀	2.382 μM Compound: Page 1994, R38C1	Cytotoxicity against human DU145 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human DU145 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
Erythrocyte	EC₅₀	>200 μg/mL Compound: 2a, beta-lapachone	Toxicity assessed as hemolytic activity against mouse erythrocyte Toxicity assessed as hemolytic activity against mouse erythrocyte	[PMID: 17827021]
Erythrocyte	EC₅₀	>50 μg/mL Compound: 2	Toxicity in mouse erythrocytes assessed as hemolytic activity after 30 mins by spectrophotometry Toxicity in mouse erythrocytes assessed as hemolytic activity after 30 mins by spectrophotometry	[PMID: 19947600]
HCT-116	IC₅₀	1.41 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
HCT-116	IC₅₀	1.575 μM Compound: Page 1994, R38C1	Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
HCT-116	IC₅₀	7.482 μM Compound: Page 1994, R38C1	Cytotoxicity against human HCT116 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
HCT-8	IC₅₀	0.31 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 17827021]
HCT-8	IC₅₀	1.36 μM Compound: 2	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 19947600]
HCT-8	IC₅₀	1.36 μM Compound: 26	Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
HCT-8	IC₅₀	1.36 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 21115213]
HL-60	IC₅₀	0.4 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 17827021]
HL-60	IC₅₀	1.75 μM Compound: 2	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 19947600]
HL-60	IC₅₀	1.75 μM Compound: 26	Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
HL-60	IC₅₀	1.75 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 21115213]
HL-60	IC₅₀	1.75 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
J774.A1	IC₅₀	3.69 μg/mL Compound: 5a; nor-beta-lap	Cytotoxicity against mouse J774.A1 cells measured after 24 hrs by resazurin based assay Cytotoxicity against mouse J774.A1 cells measured after 24 hrs by resazurin based assay	[PMID: 31378595]
Jurkat	IC₅₀	1.34 μM Compound: 26	Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
K562	IC₅₀	2.28 μM Compound: 8	Cytotoxicity against human K562 cells after 48 hrs by Alamar blue assay Cytotoxicity against human K562 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
KG-1	IC₅₀	17.2 μM Compound: 8	Cytotoxicity against human KG1 cells after 48 hrs by Alamar blue assay Cytotoxicity against human KG1 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
Lymphocyte	IC₅₀	>22 μM Compound: 8	Cytotoxicity against human lymphocytes Cytotoxicity against human lymphocytes	[PMID: 25064348]
MDA-MB-435	IC₅₀	0.07 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 17827021]
MDA-MB-435	IC₅₀	0.31 μM Compound: 2	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 19947600]
MDA-MB-435	IC₅₀	0.31 μM Compound: 26	Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
MDA-MB-435	IC₅₀	0.31 μM Compound: Nor-beta-lapachone	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 21115213]
MOLT-4	IC₅₀	13.6 μM Compound: 8	Cytotoxicity against human MOLT4 cells after 48 hrs by Alamar blue assay Cytotoxicity against human MOLT4 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
OVCAR-8	IC₅₀	1.25 μM Compound: Nor-beta-lapachone	Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
OVCAR-8	IC₅₀	13.737 μM Compound: Page 1994, R38C1	Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
OVCAR-8	IC₅₀	2.579 μM Compound: Page 1994, R38C1	Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
PBMC	IC₅₀	>21.9 μM Compound: 2	Cytotoxicity against human PBMC after 72 hrs by alamar blue assay Cytotoxicity against human PBMC after 72 hrs by alamar blue assay	[PMID: 19947600]
PBMC	IC₅₀	>21.9 μM Compound: Nor-beta-lapachone	Cytotoxicity against human PBMC cells after 72 hrs by Alamar Blue assay Cytotoxicity against human PBMC cells after 72 hrs by Alamar Blue assay	[PMID: 21115213]
PBMC	IC₅₀	>21.9 μM Compound: Nor-beta-lapachone	Cytotoxicity against human PBMC cells after 72 hrs by MTT assay Cytotoxicity against human PBMC cells after 72 hrs by MTT assay	10.1039/C4MD00371C
PBMC	IC₅₀	10 μM Compound: Page 1994, R38C1	Cytotoxicity against human PBMC assessed as decrease in cell viability after 72 hrs by Alamar blue assay Cytotoxicity against human PBMC assessed as decrease in cell viability after 72 hrs by Alamar blue assay	[PMID: 30108718]
PBMC	IC₅₀	10 μM Compound: Page 1994, R38C1	Cytotoxicity against human PBMC assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by Alamar blue assay Cytotoxicity against human PBMC assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by Alamar blue assay	[PMID: 30108718]
PBMC	IC₅₀	2.1 μM Compound: 28, Nor-beta-lapachone	Cytotoxicity against human PBMC after 72 hrs by alamar blue assay Cytotoxicity against human PBMC after 72 hrs by alamar blue assay	[PMID: 20378360]
PC-3	IC₅₀	1.453 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
PC-3	IC₅₀	1.854 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human PC3 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.401 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 96 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 96 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.787 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 96 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 96 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.887 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	2.442 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 24 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 24 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	4.587 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	8.969 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
Peritoneal macrophage cell	CC₅₀	1.55 μM Compound: Nor-beta-lapachone	Cytotoxicity against Swiss mouse peritoneal macrophages after 24 hrs by MTT assay Cytotoxicity against Swiss mouse peritoneal macrophages after 24 hrs by MTT assay	[PMID: 23535320]
SF-295	IC₅₀	0.36 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 17827021]
SF-295	IC₅₀	1.447 μM Compound: Page 1994, R38C1	Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
SF-295	IC₅₀	1.58 μM Compound: 2	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 19947600]
SF-295	IC₅₀	1.58 μM Compound: 26	Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
SF-295	IC₅₀	1.58 μM Compound: Nor-beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 21115213]
SF-295	IC₅₀	1.58 μM Compound: Nor-beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
SF-295	IC₅₀	7.404 μM Compound: Page 1994, R38C1	Cytotoxicity against human SF295 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human SF295 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
V79	IC₅₀	13 μM Compound: 8	Cytotoxicity against Chinese hamster V79 cells Cytotoxicity against Chinese hamster V79 cells	[PMID: 25064348]

化学情報

CAS 番号 52436-88-1
分子量 228.24
分子式 C₁₄H₁₂O₃
SMILES

O=C(C1=C2OC(C)(C)C1)C(C3=C2C=CC=C3)=O
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (284 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Clemente de Moraes D, et al. Effects of β-lapachone and β-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata. Bioorg Med Chem. 2022;63:116749. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

β-Nor-lapachone

生物活性

製品説明

IC₅₀ & Target

Cellular Effect

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

Bioz

Keywords

最近チェックした製品

β-Nor-lapachone

生物活性

製品説明

IC50 & Target

Cellular Effect

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

β-Nor-lapachone 関連分類

HY-146067 関連分類

Bioz

Keywords

最近チェックした製品

IC₅₀ & Target